Novo Nordisk Investors
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
Founded Date:
1923-12-21
Total Funding:
22000000
Investor Type:
Undisclosed
Employee Number:
64319
Investment Stage:
N/A
Funding Status:
IPO
Number Of Exists:
4
Technology:
Biotechnology, Health Care, Science and Engineering
Last Funding Type:
Post-IPO Equity
Acquisitions Number:
8
Investors Number:
14
Last Funding Date:
2018-12-05 00:00:00
Industry:
End-to-End Drug Development
Headquarters:
Bagsværd
Estimated Revenue:
$1B to $10B